Petya Kostadinova Argirova

Dr. Petya Kostadinova Argirova

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2023 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
PAPetya Kostadinova Argirova
Petya Kostadinova Argirova
YKYordan Kalchev
Yordan Kalchev
IBIvan Baltadzhiev
Ivan Baltadzhiev
МВМарияна Стойчева Въртигова
Марияна Стойчева Въртигова
.M.Marianna Atanassova Murdjeva
.Marianna Atanassova Murdjeva
Streptococcus equi subsp. zooepidemicus is a rare etiologic agent of bacterial meningitis in humans. The disease is a zoonotic infection and is transmitted through close contact with domestic animals, mainly horses. Only 37 cases of Streptococcus zooepidemicus meningitis have been reported in the literature until July 2023. The aim of this study is to present a rare clinical case of S. zooepidemicus-related meningitis in a human immunodeficiency virus (HIV)-positive patient and analyze the literature. We present a 23-year-old horse breeder patient with advanced immunosuppression due to acquired immunodeficiency syndrome (AIDS) and S. zooepidemicus meningitis, admitted at the Clinic of Infectious Diseases, St. George University Hospital, Plovdiv. The course of meningitis was severe since the beginning, with significant cerebral edema, disturbances in consciousness, persistent fever, and the development of complications against the background of AIDS-related conditions. S. zooepidemicus was microbiologically detected from cerebrospinal fluid culture. After prolonged treatment and a long hospital stay, the patient’s condition improved, and eventually he was discharged and recovered from the acute neuroinfection. Although extremely rare, S. zooepidemicus should be considered in patients with clinical and laboratory evidence of bacterial meningitis who have contact with animals, especially horses, other domestic animals, and their dairy products, as well as in immunocompromised patients. To the best of our knowledge, the current clinical case is the first report of S. zooepidemicus-related meningitis in a patient with HIV/AIDS.

3 June 2024 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
PAPetya Kostadinova Argirova
Petya Kostadinova Argirova
YKYordan Kalchev
Yordan Kalchev
PVPetar Vasilev
Petar Vasilev
ICIva Christova
Iva Christova
MSMariyana Stoycheva
Mariyana Stoycheva
.M.Marianna Atanassova Murdjeva
.Marianna Atanassova Murdjeva

31 October 2024 in Folia Medica
Verified
Journal Article
Open access
PDF file
PAPetya Kostadinova Argirova
Petya Kostadinova Argirova
ATAngel Todev
Angel Todev
YKYordan Kalchev
Yordan Kalchev
SZSimona Zlatanova
Simona Zlatanova
MSMariyana Stoycheva-Vartigova
Mariyana Stoycheva-Vartigova
COVID-19 presents with respiratory symptoms and signs in the majority of cases. The central nervous system can be affected directly or indirectly, which is demonstrated by a number of neurological abnormalities and complications. The aim of this study is to present a clinical case of SARS-CoV-2-associated encephalitis and highlight the severity of this neurological illness over the course of COVID-19. Etiological diagnosis methods include examination of the nasopharyngeal swab and cerebrospinal fluid by PCR. A 45-year-old man with fever, altered consciousness, and tonic-clonic seizures was admitted to the Clinic of Infectious Diseases, St George University Hospital, Plovdiv. The diagnosis of COVID-19 encephalitis is based on typical clinical and laboratory data, positive SARS-CoV-2 PCR, and exclusion of other likely causative agents into the cerebrospinal fluid. The patient was discharged two weeks after admission without neurological sequelae. The case confirms the clinical variety of COVID-19 and the possibility of severe neurological manifestations. Encephalitis is a rare but potentially life-threatening condition. Physicians should be aware of encephalitis in SARS-CoV-2 patients with neurological symptoms.

3 June 2024 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
MKMaria Hristova Kazakova
Maria Hristova Kazakova
YKYordan Kalchev
Yordan Kalchev
PAPetya Kostadinova Argirova
Petya Kostadinova Argirova
.M.Marianna Atanassova Murdjeva
.Marianna Atanassova Murdjeva
VSVictoria Sarafian
Victoria Sarafian

1 September 2026 in Acta Medica Bulgarica
Verified
Journal Article
Open access
PDF file
PAPetya Kostadinova Argirova
Petya Kostadinova Argirova
YKY. Kalchev
Y. Kalchev
AYA. Yaneva
A. Yaneva
OBO. Boykinova
O. Boykinova
Bacterial meningitis and meningoencephalitis are severe diseases that can be fatal or lead to permanent disability in survivors despite the availability of antibiotic therapy. After the emergence of SARS-CoV-2, changes in morbidity, hospitalizations and etiology have been observed in some countries. Aim : The aim of this analysis was to compare the epidemiological and clinical characteristics of patients with bacterial neuroinfections before and during COVID-19. Materials and methods : The study included 126 patients with bacterial neuroinfections, treated at the Clinic of Infectious Diseases, “Sveti Georgi” Univeristy Hospital in Plovdiv, during two equal periods – from January 2016 to September 2019 (shortly before COVID-19), and from March 2020 to December 2023 (during COVID-19), respectively. Clinical and epidemiological data, laboratory, microbiological, and molecular tests, as well as imaging techniques, were used. Results : 90 patients with bacterial neuroinfections were hospitalized during the pre-COVID-19 period, whereas hospitalizations were only 36 during the COVID-19 period. In addition, seasonal, gender, and age distribution differences were observed. The etiology was similar in both observational periods, with the most common agents being S. pneumoniae, Staphylococcus spp., and L. monocytogenes. Mortality rate was similar (33.3% vs. 37.1%, respectively), but differences in terms of etiology were observed. Conclusion : The significant reduction of bacteria I neuroinfections during the COVID-19 period is probably due to the public prevention and control measures introduced at the beginning of the pandemic. The emergence of new pathogens and the measures that society takes towards fighting them can have an impact on the epidemiology, clinical course, and prognosis of other diseases that are already known to humanity.

30 July 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
PVPetar Vasilev
Petar Vasilev
ZBZhelyazko Borisov Badarov
Zhelyazko Borisov Badarov
ATAngel Todev
Angel Todev
PAPetya Kostadinova Argirova
Petya Kostadinova Argirova
VSVelina Stoyanova Stoeva
Velina Stoyanova Stoeva
MSMariyana Stoycheva-Vartigova
Mariyana Stoycheva-Vartigova
Acute hepatitis B virus (HBV) infection is rare during infancy, and severe symptomatic HBV-associated hepatitis is even less common. We describe two siblings who developed severe HBV-associated liver injury during infancy, two years apart, but experienced markedly divergent clinical outcomes. Clinical, laboratory, virological, microbiological, imaging, therapeutic, and follow-up data were retrospectively reviewed. Household members were subsequently tested for HBV and HDV. The first infant, a 5-month-old girl, presented with HBsAg positivity, negative serological markers for HAV, HCV, and HEV, and severe acute liver injury with a fulminant clinical course that resulted in death. Because anti-HBc IgM, HBV DNA, repeat HBsAg testing, and follow-up serology were unavailable, acute HBV infection could not be confirmed, and the episode was therefore classified as presumed HBV-associated fulminant hepatitis. The rapidly fatal clinical course precluded a comprehensive etiological evaluation, and the available medical records did not fully document the diagnostic work-up. The second patient, a 4-month-old boy, presented with serological and molecular evidence of acute HBV infection, including low-level HBV DNA, total anti-HDV positivity of uncertain clinical significance, and positive CMV IgM/IgG serology. He also had a urinary tract infection (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Without HDV RNA and CMV DNA testing, active HDV infection and clinically significant CMV disease could not be definitively confirmed, while passive transfer of maternal anti-HDV antibodies could not be excluded. The patient required prolonged hospitalization, during which he received supportive, replacement, and antimicrobial therapy. He recovered, and long-term follow-up demonstrated HBsAg clearance with undetectable HBV DNA. Testing of household members revealed chronic HBV infection in the mother and maternal grandmother, both of whom had detectable HDV RNA, consistent with ongoing HBV/HDV circulation within the family. However, without viral sequence data from the infants, the source, route, timing, and direction of transmission could not be established. These cases illustrate the potential severity of HBV-associated hepatitis during infancy and its highly variable clinical outcomes. They also underscore the importance of antenatal HBV screening, timely immunoprophylaxis, and cautious interpretation of suspected viral coinfections when molecular confirmation is unavailable.